99 participants
Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2021-12-01
- Start Date:
- 2019-11-21
- Completion:
- 2020-11-18
Conditions
- Chronic Hepatitis c
Interventions
- COMBINATION_PRODUCT
No Results Yet